Statin therapy and the expression of genes that regulate calcium homeostasis and membrane repair in skeletal muscle.
Level 4 - case-series / case-control
Cross-sectional comparative study of human muscle biopsies across three clinical groups
PubMed 20489141 · doi:10.2353/ajpath.2010.091140
What was done
Researchers evaluated skeletal muscle biopsies from 72 age-matched human subjects across three cohorts: patients currently receiving statin therapy (n = 38), patients who had discontinued statins due to clinically diagnosed statin-associated myopathy (n = 14), and statin-naive controls (n = 20). Microscopic evaluation and gene expression profiling were conducted using custom TaqMan arrays focused on selected genes involved in calcium regulation, membrane repair, lipid homeostasis, myocyte remodeling, and mitochondrial function.
What was found
In asymptomatic, statin-treated patients, statin use was associated with broad changes in the expression of genes governing calcium regulation and membrane repair machinery, whereas genes regulating mitochondrial function and myocyte remodeling were unaffected. Discontinuation of statins after myopathic symptoms normalized most gene expression levels back toward control levels, with the exception of persistent alterations in genes encoding ryanodine receptor 3, calpain 3, and dystrophin. The abstract reports directional findings only and does not provide specific numerical values, fold changes, or p-values.
Why it matters
These findings suggest that statin therapy alters skeletal muscle molecular pathways involved in calcium handling and membrane maintenance even in patients who lack clinical symptoms of myopathy, providing mechanistic clues into statin-related muscle side effects.
Limits
The study is limited by a small total sample size (n = 72 divided among three subgroups) and a cross-sectional, observational design, which cannot establish within-individual longitudinal changes. The abstract does not report specific statin types, dosages, treatment durations, or quantitative effect sizes and statistical significance thresholds.
Cited by
- contradicts Almost everyone taking a statin shows damaged mitochondria on a muscle biopsy, even in the absence of muscle pain or elevated creatine phosphokinase (CPK).